AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2026
Jan 9, 2026
33651_dirs_2026-01-09_327ee171-6abc-4ba1-ace1-60bef02beb1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2026-01-07
Reporting Person: VAN NOSTRAND ROBERT L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-07 | Common Stock | A | 50000 | $0.00 | Acquired | 82900 | Direct |
Footnotes
F1: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
More from SELLAS Life Sciences Group, Inc.
Board/Management Information
2026
Jun 25
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 18
Share Issue/Capital Change
2026
Jun 16
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9